US BROKER MOVES: AVGO upgraded at Macquarie; MRNA downgraded at Rothschild Redburn

• Amalgamated Financial (AMAL) upgraded from Neutral to Outperform; PT USD 55 at Raymond James
• Broadcom (AVGO) upgraded from Neutral to Outperform at Macquarie
• BWX Technologies (BWXT) upgraded from Neutral to Buy; PT USD 181 at Jefferies
• Copart (CPRT) upgraded from Neutral to Overweight; PT USD 40 (prev. USD 32) at JPMorgan
• Envista Holdings (NVST) upgraded from Neutral to Overweight; PT USD 32 (prev. USD 29) at JPMorgan

• Brookfield Asset Management (BAM) downgraded from Outperform to Market Perform; PT USD 91 at Itau BBA
• Fluence Energy (FLNC) downgraded from Equalweight to Underweight; PT USD 10 (prev. USD 16) at Barclays
• Grupo Financiero Galicia (GGAL) downgraded from Outperform to Market Perform; PT USD 60 at Itau BBA
• Moderna (MRNA) downgraded from Neutral to Sell; PT USD 81 (prev. USD 40) at Rothschild Redburn
• NIO (NIO) downgraded from Buy to Hold; PT USD 4 (prev. USD 7) at Freedom Broker
• Pacific Gas & Electric (PCG) downgraded from Buy to Hold; PT USD 17 (prev. USD 21) at Truist Securities
• Sonoco Products (SON) downgraded from Buy to Neutral; PT USD 60 (prev. USD 69) at BofA Securities

• Broadcom (AVGO) initiated Buy; PT USD 600 at Rosenblatt
• BWX Technologies (BWXT) initiated Buy; PT USD 181 at Jefferies
• Liberty Latin America (LILAK) initiated Neutral; PT USD 9 at UBS
• Pagaya Technologies (PGY) initiated Buy at TD Cowen
• Prudential (PUK) initiated Buy; PT USD 39.30 at Berenberg
• RingCentral (RNG) initiated Outperform; PT USD 85 at RBC Capital
• Tiziana Life Sciences (TLSA) initiated Buy; PT USD 7 at BTIG
• Thermo Fisher Scientific (TMO) initiated Outperform; PT USD 748 at CLSA
• Uranium Energy (UEC) initiated Hold; PT USD 11.50 at Jefferies
• Vishay Intertechnology (VSH) initiated Buy; PT USD 42 at Truist Securities

Daily broker roundups of this size tend to move only the names involved, and usually only at the open; sustained repricing has historically required either a large-cap with heavy index weight or a call that breaks decisively from consensus. Broadcom features twice, an upgrade at Macquarie and a Buy initiation at Rosenblatt, and clustered positive coverage on a megacap has tended to matter more through the peer set than through the single stock, with read-through to the broader AI semiconductor complex when the framing is thematic rather than idiosyncratic. The Moderna call is the notable outlier on the sheet: a downgrade to Sell paired with a price target above the prior one, an unusual combination that in past episodes has reflected either a sharp rally having carried the stock well past fair value or a change in coverage assumptions, and the underlying thesis note is the follow-on that separates the two. Elsewhere the downgrades skew toward rate-sensitive and policy-exposed names, including a utility and an Argentine financial, where analyst revisions have tended to lag rather than lead the macro driver. As with most roundup sessions, the durable signal is whether the calls cluster around a theme, here the double Broadcom endorsement, rather than any individual rating change.